Monsanto has secured its second Philadelphia Roundup verdict.

A jury determined Wednesday that Monsanto’s Roundup weedkiller was defective, but the defect did not cause plaintiff Ryan Young’s non-Hodgkin lymphoma. It also found that neither Monsanto nor its co-defendant, chemical manufacturer Nouryon, were negligent.